Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

[A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].

Tytuł:
[A case of stage IV advanced esophageal cancer with a long term survival by radiation therapy combined with nedaplatin and 5-FU chemotherapy].
Autorzy:
Morimoto J; Department of Surgical Oncology, Osaka City University Graduate School Division of Medicine.
Oohira M
Kubo N
Tanaka H
Dan N
Muguruma K
Yashiro M
Sawada T
Yamashita Y
Nishiguchi Y
Hirakawa K
Źródło:
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2009 Nov; Vol. 36 (12), pp. 2436-8.
Typ publikacji:
Case Reports; English Abstract; Journal Article
Język:
Japanese
Imprint Name(s):
Publication: Tokyo : Gan To Kagaku Ryohosha
Original Publication: Tōkyō, Gan to Kagaku Ryōhōsha [1974?]-
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Esophageal Neoplasms/*therapy
Aged ; Antimetabolites, Antineoplastic/administration & dosage ; Antineoplastic Agents/administration & dosage ; Combined Modality Therapy ; Esophageal Neoplasms/pathology ; Esophagectomy ; Fluorouracil/administration & dosage ; Gastrectomy ; Humans ; Male ; Neoplasm Staging ; Neoplasms, Multiple Primary/pathology ; Neoplasms, Multiple Primary/therapy ; Organoplatinum Compounds/administration & dosage ; Stomach Neoplasms/pathology
Substance Nomenclature:
0 (Antimetabolites, Antineoplastic)
0 (Antineoplastic Agents)
0 (Organoplatinum Compounds)
8UQ3W6JXAN (nedaplatin)
U3P01618RT (Fluorouracil)
Entry Date(s):
Date Created: 20091229 Date Completed: 20100218 Latest Revision: 20131121
Update Code:
20240104
PMID:
20037448
Czasopismo naukowe
The patient was a 73-year-old man who complained of dysphagea. Various examinations revealed an esophageal cancer with direct invasion to the left main bronchus (cT4, N2 (104R, 106recR), M0, Stage IVa) and gastric cancer (cT2, N0, M0, Stage IB). The patient was given preoperative chemoradiotherapy (40 Gy/20 fr with CDGP 10 mg/body day 1-5, 8- 12, 15-19 and 5-FU 250 mg/body day 1-5, 8-12, 15-19). After the chemoradiotherapy, we estimated that the esophageal cancer was down stage (cT4-->T3), and that a curative operation was possible. Therefore, subtotal esophagectomy and partial gastrectomy were performed without a complication. Pathological therapeutic evaluation of the esophageal cancer was complete response (CR) and the gastric cancer was T2, N0. Adjuvant chemotherapy was undergone with S-1. However, two years after the first operation, we found a recurrence of gastric duct. Therefore a surgical resection for recurrence of gastric duct was performed. The patient is still alive without recurrence 5 years and 2 months after the first treatment. Radiation therapy combined with nedaplatin and 5-FU is a safe and effective method for treating cT4 advanced esophageal cancer.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies